Workday, Inc.
$38.53B- Market cap
- $40.98B
- Debt
- +$2.99B
- Cash
- −$5.44B
Capital structure 93% equity / 7% debt · EV / Revenue 4.03x · EV / EBITDA 28.41x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $40.98B · View financials
Snapshot Sep 8, 10:14 AM ET
FY 2024 ·
Decision snapshot: WDAY stock price vs SAGE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SAGE's multiple
Needs SAGE P/E.
Implied fair value · at WDAY's multiple
Needs EPS (TTM) is negative.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: WDAY FY 2026 (ended Jan 31, 2026) · SAGE FY 2024 (ended Dec 31, 2024). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 93% equity / 7% debt · EV / Revenue 4.03x · EV / EBITDA 28.41x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WORKDAY, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Sage Therapeutics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.38x
0.17x
Net debt / EBITDA
Leverage against operating earnings
-1.81x
1.06x
Cash and equivalents
Liquid reserves on the balance sheet
$5.44B
$504.42M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Salesforce, Inc.
WDAY vs CRM
Oracle Corporation
WDAY vs ORCL
INTUIT INC.
WDAY vs INTU
AUTOMATIC DATA PROCESSING INC
WDAY vs ADP
Paycom Software, Inc.
WDAY vs PAYC
BIOGEN INC.
WDAY vs BIIB
ELI LILLY & Co
WDAY vs LLY
SUPERNUS PHARMACEUTICALS, INC.
WDAY vs SUPN
Harmony Biosciences Holdings, Inc.
WDAY vs HRMY
$2.99B
$80.68M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.